150 related articles for article (PubMed ID: 8752454)
1. [Prevalence and founder effect of Huntington's disease in the San-in area of Japan].
Nakashima K; Watanabe Y; Kusumi M; Nanba E; Maeoka Y; Igo M; Irie H; Ishino H; Fujimoto A; Kobayashi S
Rinsho Shinkeigaku; 1995 Dec; 35(12):1532-4. PubMed ID: 8752454
[TBL] [Abstract][Full Text] [Related]
2. [Population genetic study of Huntington's disease--prevalence and founder's effect in the San-in area, western Japan].
Adachi Y; Nakashima K
Nihon Rinsho; 1999 Apr; 57(4):900-4. PubMed ID: 10222787
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan.
Nakashima K; Watanabe Y; Kusumi M; Nanba E; Maeoka Y; Nakagawa M; Igo M; Irie H; Ishino H; Fujimoto A; Goto J; Takahashi K
Neuroepidemiology; 1996; 15(3):126-31. PubMed ID: 8700304
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetics of Huntington's disease].
Goto J; Masuda N; Watanabe M; Kanazawa I
Rinsho Shinkeigaku; 1995 Dec; 35(12):1529-31. PubMed ID: 8752453
[TBL] [Abstract][Full Text] [Related]
5. Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis.
Dodé C; Dürr A; Pêcheux C; Mouret JF; Belal S; Bachner L; Agid Y; Kaplan JC; Brice A; Feingold J
C R Acad Sci III; 1993 Nov; 316(11):1374-80. PubMed ID: 8087617
[TBL] [Abstract][Full Text] [Related]
6. DNA haplotype analysis of CAG repeat in Taiwanese Huntington's disease patients.
Wang CK; Wu YR; Hwu WL; Chen CM; Ro LS; Chen ST; Gwinn-Hardy K; Yang CC; Wu RM; Chen TF; Wang HC; Chao MC; Chiu MJ; Lu CJ; Lee-Chen GJ
Eur Neurol; 2004; 52(2):96-100. PubMed ID: 15273431
[TBL] [Abstract][Full Text] [Related]
7. 4p16.3 haplotype modifying age at onset of Huntington disease.
Nørremølle A; Budtz-Jørgensen E; Fenger K; Nielsen JE; Sørensen SA; Hasholt L
Clin Genet; 2009 Mar; 75(3):244-50. PubMed ID: 19250382
[TBL] [Abstract][Full Text] [Related]
8. [The gene responsible for Huntington's disease in Spanish families: its diagnostic value and the relation between trinucleotide expansion and the clinical characteristics].
Benítez J; Fernández E; García Ruiz P; Robledo M; Ayuso C; García Yébenes J
Rev Clin Esp; 1994 Aug; 194(8):591-3. PubMed ID: 7938836
[TBL] [Abstract][Full Text] [Related]
9. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease.
Myers RH; MacDonald ME; Koroshetz WJ; Duyao MP; Ambrose CM; Taylor SA; Barnes G; Srinidhi J; Lin CS; Whaley WL
Nat Genet; 1993 Oct; 5(2):168-73. PubMed ID: 8252042
[TBL] [Abstract][Full Text] [Related]
10. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
11. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
[TBL] [Abstract][Full Text] [Related]
12. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
Vassos E; Panas M; Kladi A; Vassilopoulos D
J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
[TBL] [Abstract][Full Text] [Related]
13. Huntington's Disease-like 2 (HDL2) in North America and Japan.
Margolis RL; Holmes SE; Rosenblatt A; Gourley L; O'Hearn E; Ross CA; Seltzer WK; Walker RH; Ashizawa T; Rasmussen A; Hayden M; Almqvist EW; Harris J; Fahn S; MacDonald ME; Mysore J; Shimohata T; Tsuji S; Potter N; Nakaso K; Adachi Y; Nakashima K; Bird T; Krause A; Greenstein P
Ann Neurol; 2004 Nov; 56(5):670-4. PubMed ID: 15468075
[TBL] [Abstract][Full Text] [Related]
14. [Molecular diagnosis of Huntington's disease: an analysis of two large families].
Zeng Y; Chen M; Mao Y
Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):689-93, 711-2. PubMed ID: 8697093
[TBL] [Abstract][Full Text] [Related]
15. Trinucleotide repeat length instability and age of onset in Huntington's disease.
Duyao M; Ambrose C; Myers R; Novelletto A; Persichetti F; Frontali M; Folstein S; Ross C; Franz M; Abbott M
Nat Genet; 1993 Aug; 4(4):387-92. PubMed ID: 8401587
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Huntington's disease in Slovenia.
Peterlin B; Kobal J; Teran N; Flisar D; Lovrecić L
Acta Neurol Scand; 2009 Jun; 119(6):371-5. PubMed ID: 18976322
[TBL] [Abstract][Full Text] [Related]
17. Assessment of simple movements reflects impairment in Huntington's disease.
Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
[TBL] [Abstract][Full Text] [Related]
18. Advances in Huntington's disease diagnostics: development of a standard reference material.
Levin BC; Richie KL; Jakupciak JP
Expert Rev Mol Diagn; 2006 Jul; 6(4):587-96. PubMed ID: 16824032
[TBL] [Abstract][Full Text] [Related]
19. Case of the month: August 1997--a 13 year old girl with progressive movement disorder.
Hofgärtner WT; La Spada AR; Tait JF
Brain Pathol; 1998 Jan; 8(1):237-8. PubMed ID: 9458182
[TBL] [Abstract][Full Text] [Related]
20. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
